There are 2949 resources available
HER past: Looking back on two decades of HER2-targeted therapy
Presenter: Fatima Cardoso
Session: AstraZeneca - HER tomorrow in HER2+ metastatic breast cancer
Resources:
Webcast
HER new potential: New advances in HER2+ breast cancer treatment
Presenter: Erika Hamilton
Session: AstraZeneca - HER tomorrow in HER2+ metastatic breast cancer
Resources:
Webcast
Sharing HER experience: Case-based panel discussion
Presenter: Erika Hamilton
Session: AstraZeneca - HER tomorrow in HER2+ metastatic breast cancer
Resources:
Webcast
Closing remarks
Presenter: Eva Ciruelos
Session: AstraZeneca - HER tomorrow in HER2+ metastatic breast cancer
Resources:
Webcast
Welcome and introduction
Presenter: Pasi Jänne
Session: Daiichi Sankyo -Antibody Drug Conjugates (ADCs): Advancements in the treatment of solid tumours
Resources:
Webcast
ADCs as a technologically advanced treatment approach in solid tumours
Presenter: Pasi Jänne
Session: Daiichi Sankyo -Antibody Drug Conjugates (ADCs): Advancements in the treatment of solid tumours
Resources:
Webcast
Current clinical experience with innovative ADCs in breast cancer
Presenter: Javier Cortés
Session: Daiichi Sankyo -Antibody Drug Conjugates (ADCs): Advancements in the treatment of solid tumours
Resources:
Webcast
Latest findings from clinical trials in lung cancer with technologically advanced ADCs
Presenter: Pasi Jänne
Session: Daiichi Sankyo -Antibody Drug Conjugates (ADCs): Advancements in the treatment of solid tumours
Resources:
Webcast
Recent clinical findings with novel ADCs in colorectal and gastric cancer
Presenter: Kanwal Raghav
Session: Daiichi Sankyo -Antibody Drug Conjugates (ADCs): Advancements in the treatment of solid tumours
Resources:
Webcast
Summary and close
Presenter: Pasi Jänne
Session: Daiichi Sankyo -Antibody Drug Conjugates (ADCs): Advancements in the treatment of solid tumours
Resources:
Webcast